MedPath

A proof of concept study on the effect of tianeptine on opioid-­induced respiratory depressio

Recruiting
Conditions
Opioid geïnduceerde ademdepressie
Respiratory depression and reduced breathing
Registration Number
NL-OMON40468
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

Age of 18 to 35 years (inclusive);;Body Mass Index (BMI) between 18 and 35 kg/m2 (inclusive) and body weight between 50 kg and 100 kg (inclusive);;Subject is able to read and understand the written consent form, complete study­*related procedures, and communicate with the study staff;;Subject is willing to comply with study restrictions

Exclusion Criteria

Clinically relevant abnormal history of physical and mental health, as determined by medical history taking and physical examinations obtained during the screening visit and/or prior to the administration of the initial dose of the study drug (as judged by the investigator); ;A semi recumbent systolic blood pressure of >160 mmHg and/or diastolic blood pressure of > 95 mmHg at screening; ;History of alcoholism or substance abuse within three years prior to screening; ;Positive pregnancy test; ;Subjects using more than 20 units of alcohol per week;
Use of medication during the study period;
If sexually active, the subject is not using oral contraceptives, or surgically sterilized; ;Subject has a history of severe allergies, or has had an anaphylactic reaction or significant intolerability to prescription or non-*prescription drugs or food; ;Participation in an investigational drug trial in the 2 months prior to administration of the initial dose of study drug or more than 5 times per year; ;Any other condition that in the opinion of the investigator would
complicate or compromise the study, or the wellbeing of the subject.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To assess the respiratory effects of an oral dose of tianeptine on alfentanil*<br /><br>induced respiratory depression</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To assess the antinociceptive effects of an oral dose of tianeptine during<br /><br>alfentanil-­infusion. </p><br>
© Copyright 2025. All Rights Reserved by MedPath